| Application no. and date | 03722519.0 (espacenet) (Federated) (European Patent Register), 20030422 | | Patent/reg. no. and date | DK/EP 1501485, 20070926 | | Publication date | 20050202 | | Priority no. and date | GB 0209265, 20020423 | | EP pub. no. and date |
EP 1501485 20050202 | | Effective date | | | Applicant/owner | Novartis AG, Lichtstrasse 35
4056 Basel, CH | | Applicant ref. no. | SH/GP/131038 | | Inventor | LUFTENSTEINER, Christian-Peter, Am Rheinpark 2
79576 Weil am Rhein, DE,
BIANCHI, Jean-Claude, Rue Kellergraben
68730 Blotzheim, FR,
OGORKA, Jörg, Im Steinbrunnen 19/3
79585 Steinen, DE,
KALB, Oskar, Belchenstrasse 9
79539 Lörrach, DE | | Representative | Budde Schou A/S, Dronningens Tværgade 30, 1302 København K | | Opponent | | | IPC Class | A61K 31/505 (2006.01) , A61K 47/32 (2006.01) , A61K 47/38 (2006.01) , A61K 9/16 (2006.01) , A61K 9/26 (2006.01) , A61K 9/28 (2006.01) | | Title | Tablet med højt indhold af aktivt stof | | Int. application no. | EP2003004151 | | Int. publication no. | WO2003090720 | | Related patent (certificate) | | | Status | Ophævet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
